Blood
Global access to commercial CAR T cells: A cross-sectional study of health technology assessment in the G20.
Alex Y Ge, William B Feldman, Martin F Kaiser, Kai Rejeski, Gloria Iacoboni, Gaurav Narula, Jason Yongsheng Chan, Michael Dickinson, Aaron S Kesselheim, Edward Robert Scheffer Cliff
Published: 202610.1182/blood.2025030872
Abstract
Chimeric antigen receptor T-cells (CAR T) are a major treatment advance for many patients with haematological malignancies, especially those with disease that has relapsed or is refractory to chemotherapy. However, currently approved commercial CAR T…
Preview only. Read the full abstract at the source